Gur RE, Bassett AS, McDonald-McGinn DM, Bearden CE, Chow E, Emanuel BS, et al
Given these industry-wide quality issues, careful source selection is essential
AOD 9604: Chemical Identity AOD 9604 is a synthetic growth hormonederived peptide fragment corresponding to the C-terminal lipolytic region of human GH, with an additional N-terminal tyrosine residue incorporated to improve structural stability in laboratory systems
Clinical studies demonstrate that patients treated with tirzepatide achieve an average weight reduction exceeding 10 kilograms, substantially outperforming single-agonist therapies
GLP-1 receptor agonist drugs (called GLP-1s for short) like semaglutide work by mimicking this hormone, increasing insulin release (which helps control diabetes), signaling your brain that you're full, and slowing digestion
PMID: 17403099 30